Risk Factors Associated With Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis in a Real‐World Setting in Japan
International Journal of Rheumatic Diseases · 2024
DOI: 10.1111/1756-185x.15448 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2024. Verfasst von Kunihiro Yamaoka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Neoplasms, Cardiovascular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.
Abstract (Originalsprache)
Aim
To identify risk factors associated with major adverse cardiovascular events (MACE) and malignancies in patients with rheumatoid arthritis (RA) using real‐world data from Japan.
Methods
This cohort study used the Real World Data database of medical institutions in Japan. Eligible patients (January 2013–December 2021) had ≥ 1 RA diagnosis, were aged ≥ 18 years, prescribed ≥ 1 antirheumatic drug, had no psoriasis diagnosis, and had a record postindex. Patients had no myocardial infarction/stroke ≤ 31 days (MACE cohort) or malignancy < 1 year (malignancy cohort) before index. Cohorts were determined by incidence of initial MACE or malignancy. Known/exploratory variables were selected using Cox regression models.
Results
Across MACE ( n = 16 012) and malignancy ( n = 14 545) cohorts, most patients were female and aged ≥ 65 years. Overall, 214 MACE per 43964.7 patient‐years (incidence rate 0.49 per 100 patient‐years) and 315 malignancies per 40251.6 patient‐years (incidence rate 0.78 per 100 patient‐years) occurred. Male sex, older age (≥ 65 years), hypertension, renal disease, cerebrovascular disease, and prior X‐ray examination were significantly associated with increased MACE risk. Male sex, older age (≥ 50 years), nonsteroidal anti‐inflammatory drug use, emphysema, serious infection, malignancy history, and prior X‐ray examination were significantly associated with increased malignancy risk. Conversely, glucocorticoid use and fracture diagnosis were significantly associated with reduced malignancy risk.
Conclusion
In patients with RA in Japan, male sex, older age, and prior X‐ray examination were associated with increased MACE and malignancy risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan.
- Pfizer Japan Inc, Tokyo, Japan.
- Pfizer Pharmaceuticals Korea Ltd, Seoul, South Korea.
- Division of Rheumatology, Seoul Metropolitan Government-Seoul National University, Boramae Medical Center, Seoul, South Korea.
ORCID-Profile: Kunihiro Yamaoka, Kichul Shin
Förderung
- Pfizer
Zitieren
APA
Yamaoka, K., Sugiyama, N., Hoshi, M., Jo, J. Y., Shin, K., & Hirano, T. (2024). Risk Factors Associated With Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis in a Real‐World Setting in Japan. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.15448
Vancouver
Yamaoka K, Sugiyama N, Hoshi M, Jo JY, Shin K, Hirano T. Risk Factors Associated With Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis in a Real‐World Setting in Japan. International Journal of Rheumatic Diseases. 2024. doi:10.1111/1756-185x.15448
BibTeX
@article{Yamaoka2024,
author = {Yamaoka, Kunihiro and Sugiyama, Naonobu and Hoshi, Masato and Jo, Joo-Young and Shin, Kichul and Hirano, Toshitaka},
title = {Risk Factors Associated With Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis in a Real‐World Setting in Japan},
journal = {International Journal of Rheumatic Diseases},
year = {2024},
doi = {10.1111/1756-185x.15448}
}
EUVIMED